Trimi vs RxSpan MD
Both clinics sit in our top 10, so this page exists for readers already comparing them here. It is not written for search and is not submitted for indexing. Every figure below is read from the clinic's own page, with the date.
26 of the 51 clinics we rank are an affiliate partner. Scores come only from our published methodology. At equal displayed scores, active affiliate partners are listed first. What it changes is which clinic a promoted button points at, and every such link carries a PICK badge in the table so you can see it before you click.
Says outright that its headline is a monthly equivalent of annual billing, and prints the no-commitment rate beside it instead of leaving you to find it at checkout.
from $99/mo on a 12-month prepaid plan
Verified 2026-09-21
PickBoth GLP-1 molecules in both routes plus three real brand names, and a medication-comparison page that cites 11 primary sources by DOI and rates its own compounded capsules' efficacy as "Unknown". From a practice that publishes neither its pharmacy, nor the states it ships to, nor any refund terms behind a $2,327 upfront charge.
from $175/mo on a 12-month plan ($2,094 upfront)
Verified 2026-09-14
Visit →Affiliate link
| Trimi | RxSpan MD | |
|---|---|---|
| Price | from $99/mo on a 12-month prepaid planTheir page, read 2026-09-21 | from $175/mo on a 12-month plan ($2,094 upfront)Their page, read 2026-09-14 |
| Price shape | one-ongoing-rate | one-ongoing-rate |
| What the price doesn’t say | $99/mo is a monthly equivalent of $1,188 billed upfront on a 12-month commitment. Not a month you can pay and stop. With no commitment it is $175/mo. Tirzepatide is $125/mo on the same 12-month basis, or $235/mo with no commitment. | $175/mo is the 12-month plan, billed as a single upfront payment of $2,094 with the STARTNOW promo already applied in the display. It is the rate for the whole term, not a first-month discount. $2,094 over 12 months works out at $174.50. The $194/mo you may also see is the pre-promo figure. Tirzepatide is $243/mo ($2,905). What is not published: no state list, no named pharmacy, no cancellation terms. |
| What it covers | 12 months of compounded semaglutide, supplies, licensed provider care, ongoing support and free overnight shippingTheir page, read 2026-09-21 | Not published. The page does not say what the figure covers.Their page, read 2026-09-14 |
| Billed on top | Not recorded. We have not found a statement either way.Their page, read 2026-09-21 | Not recorded. We have not found a statement either way.Their page, read 2026-09-14 |
| Commitment | Committed term. The rate applies on a 12-month prepaid plan. Billed up front on that term. What happens after the first period: Trimi states on the page that the figures shown are monthly equivalents of annual billing, and prints the no-commitment rate ($175/mo semaglutide, $235/mo tirzepatide) next to them.Their page, read 2026-09-21 | The page does not state whether a term is required.Their page, read 2026-09-14 |
| Routes | compounded semaglutide, compounded tirzepatide | compounded semaglutide, compounded tirzepatide, oral semaglutide capsules, oral tirzepatide capsules, brand-name Ozempic/Wegovy/Zepbound |
| Score | 7.9 | 7.3 |
What one does that the other doesn’t
Trimi
Nothing RxSpan MD does not also offer, on the routes we record.
RxSpan MD
Offers oral/sublingual, brand-name where Trimi does not.
Who each one suits
Every line below is a difference we can measure, with the field or criterion it comes from. Where a side is empty, nothing in what we record favours it. We would rather say that than invent a reason.
Trimi
- Lower published entry figure of the two.Basis: published entry price, each in its own billing unit
- Scores clearly higher on transparency (9.0 vs 6.5).Basis: our published scoring rubric
- Scores clearly higher on pricing (8.5 vs 6.0).Basis: our published scoring rubric
RxSpan MD
- Requires no committed term as far as its page says. But its page does not state one either way.Basis: commitment term not stated on the clinic's page
- Only one of the two offering: oral/sublingual, brand-name.Basis: published treatments, by drug and route
- Scores clearly higher on treatment (9.0 vs 6.5).Basis: our published scoring rubric